Get the Stockscreener App
0.8216
3.01%
-0.0255
After Hours:
.82
-0.0016
-0.19%
Biofrontera Inc stock is traded at $0.8216, with a volume of 202.86K.
It is down -3.01% in the last 24 hours and down -32.10% over the past month.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
See More
Previous Close:
$0.8471
Open:
$0.8805
24h Volume:
202.86K
Relative Volume:
0.64
Market Cap:
$12.20M
Revenue:
$43.20M
Net Income/Loss:
$-11.09M
P/E Ratio:
-0.741
EPS:
-1.1088
Net Cash Flow:
$-9.32M
1W Performance:
-15.30%
1M Performance:
-32.10%
6M Performance:
-23.93%
1Y Performance:
-17.01%
1-Day Range:
$0.8215
$0.92
1-Week Range:
$0.82
$0.9997
52-Week Range:
$0.5547
$1.66
Biofrontera Inc Stock (BFRI) Company Profile
Name
Biofrontera Inc
Sector
Phone
781-245-1325
Address
120 PRESIDENTIAL WAY,, WOBURN
Compare BFRI vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BFRI
Biofrontera Inc
|
0.8216 | 12.20M | 43.20M | -11.09M | -9.32M | -1.1088 |
TAK
Takeda Pharmaceutical Co Adr
|
19.67 | 62.84B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.50 | 48.40B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
10.13 | 44.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
79.38 | 32.80B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
533.12 | 22.87B | 3.17B | 1.29B | 1.01B | 27.09 |
Biofrontera Inc Stock (BFRI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-19-26 | Downgrade | The Benchmark Company | Buy → Speculative Buy |
Biofrontera Inc Stock (BFRI) Latest News
Biofrontera Warrants (BFRIW) Hold Flat at $0.01 as Trading Activity Remains SubduedStock Picks - https://www.siam.in/
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Biofrontera (NasdaqCM:BFRI) Stock Forecast & Analyst Predictions - Simply Wall Street
Form 8K Biofrontera Inc For: 14 September By Investing.com - Investing.com Nigeria
Form 8K Biofrontera Inc For: 14 September By Investing.com - Investing.com UK
The FDA approved the first and only light treatment for a skin cancer - Stock Titan
Biofrontera Warrants (BFRIW) Hold Near $0.02 as Sub-Penny Instrument Edges LowerFear Greed Index - careplusvn.com
Biofrontera Warrants (BFRIW) Hold Near $0.02 as Sub-Penny Instrument Edges LowerMomentum Factor - siam.in
Biofrontera Warrants (BFRIW) Hold Near $0.02 as Sub-Penny Instrument Edges LowerTrading Ideas - www.dars.gov.et
Biofrontera (NASDAQ:BFRI) Passes Minervini Trend Template With High-Growth Momentum - ChartMill
BFRI Q2 2026 Earnings: Loss Narrows Sharply, Delivering 53% EPS BeatEarnings Acceleration Picks - vinanet.vn
Biofrontera (BFRI) Jumps 6.71% to $1.59, Testing Key Resistance Near $1.67Common Gap - vinanet.vn
Biofrontera Inc. Warrants (BFRIW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Biofrontera (BFRI) Quarterly Figures: Profit Per Share Clears Its Benchmark on the Day; Share Move: Shares Show Little Net Change in Latest TradingRevenue Inflection Point - vinanet.vn
Biofrontera (BFRI) Q2 2026 Earnings Call Transcript - AOL.com
Biofrontera (BFRI) Q2 2026 Earnings Call Transcript - The Globe and Mail
Biofrontera (BFRI) Close and Levels: Posts a 6.67% Gain to $1.44 in the Current Update; Trading Range: Price Remains Between $1.37 Support and $1.51 Resistance on the DayCall Spread Alert - vinanet.vn
Biofrontera (BFRI) Close and Levels: Posts a 6.67% Gain to $1.44 in the Current Update; Trading Range: Price Remains Between $1.37 Support and $1.51 Resistance on the DayGamma Flip Level - dars.gov.et
Ziopharm: Q2 Earnings Snapshot - AOL.com
Biofrontera (BFRI) Climbs 3.17% to $1.30: Holding Above Key Support ZonePCR Divergence - vinanet.vn
Biofrontera Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Biofrontera Q2 2026 Earnings Call Transcript - marketbeat.com
Biofrontera Inc (BFRI) (Q2 2026) Earnings Call Highlights: Strong Ameluz Growth Drives Revenue ... - Yahoo Finance
Biofrontera Inc. (BFRI) lifts revenue yet flags going concern and ITC impact - Stock Titan
Biofrontera Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BFRI Q2 2026 Earnings: Narrower-Than-Expected Loss Drives 6.4% Stock RallyEarnings Weakness Phase - vinanet.vn
Same Patent, Same Light- Director Vacates IPR Decision at Odds With ITC Decision - The National Law Review
Biofrontera earnings beat by $0.09, revenue topped estimates - Investing.com
Earnings call transcript: Biofrontera tops Q2 2026 estimates, shares jump 9.6% - Investing.com
BFRI: Record revenue growth, margin expansion, and strong pipeline offset ITC lamp restriction - TradingView
Biofrontera Inc. (BFRI) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Price to earnings forward of Biofrontera Inc. – BOATS:BFRIW - TradingView
Biofrontera Inc. (BFRI) Q2 FY2026 earnings call transcript - Yahoo Finance
Form 8K Biofrontera Inc For: 13 August By Investing.com - Investing.com Australia
Form 8K Biofrontera Inc For: 13 August By Investing.com - Investing.com Nigeria
BIOFRONTERA ($BFRI) Releases Q2 2026 Earnings - Quiver Quantitative
Form 8K Biofrontera Inc For: 13 August By Investing.com - Investing.com India
Biofrontera Reports Q2 2026 Revenue Up 33% to $12.0M, Gross Margin 80% - TradingView
Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth - The Manila Times
Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth - marketscreener.com
Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth - Yahoo Finance
Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth - GlobeNewswire
Biofrontera (BFRI) investor Rosalind discloses 9.9% stake and 9.99% blocker - Stock Titan
Earnings To Watch: Biofrontera Inc (BFRI) Q2 2026 -- GF Value Sees 51% Downside - Yahoo Finance
Earnings To Watch: Biofrontera Inc (BFRI) Q2 2026 -- GF Value Se - GuruFocus
Biofrontera Inc. Warrants (BFRIW) Hold Steady at $0.03 as Support and Resistance ConvergeMAMA Signal - dars.gov.et
Biofrontera Inc. Warrants (BFRIW) Hold Steady at $0.03 as Support and Resistance ConvergeInsider Sentiment - www.dars.gov.et
Biofrontera Inc. (BFRI) Stock Major Holders - Yahoo! Finance Canada
Price to sales forward of Biofrontera Inc. – BOATS:BFRIW - TradingView
Biofrontera Inc (BFRI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Biofrontera Inc Stock (BFRI) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.26%
5.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):